20250188102. Triazine Compound, Int (JKT BIOPHARMA ., .)
TRIAZINE COMPOUND, INTERMEDIATE THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF
Abstract: a triazine compound, an intermediate thereof, and a preparation method therefor and the use thereof. specifically, the present invention relates to a triazine derivative as represented by formula (i′) or a pharmaceutically acceptable salt thereof. on the basis of retaining the effectiveness against sars-cov-2, the compound significantly prolongs the half-life period, reduces the dosage requirement, reduces side effects, expands the range of therapeutic window, and has very good prospects when used for manufacturing a drug for treating diseases related to coronavirus infections.
Inventor(s): Xiaokun SHEN, Jinwen HUANG
CPC Classification: C07F9/65583 (ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins ))
Search for rejections for patent application number 20250188102